Plain-English translation of NCT02863172 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers at M.D. Anderson Cancer Center are trying to understand why hereditary colorectal cancer develops differently in different people. By collecting health questionnaires and blood or saliva samples from patients with hereditary colorectal cancer and their relatives, the study aims to identify genetic factors that explain these differences. This knowledge could help doctors predict risk and guide treatment decisions for families affected by this condition.
Hereditary colorectal cancer syndrome runs in families, but doctors don't fully understand why some family members develop cancer earlier or more severely than others. This research aims to close that gap by studying the genetics behind these variations, which could eventually lead to better prevention and monitoring strategies.
You likely qualify if…
You likely don't qualify if…
If you join, you'll complete questionnaires about your family history, work, medical history, and health habits — either online, by phone, by mail, or in person — which takes about 30 minutes total. You'll also provide a blood sample (about 2–3 tablespoons) or a saliva sample if you prefer, which researchers will analyze for genetic information. At least once over the next 5 years, you'll be asked to complete a follow-up questionnaire to update your health information.
AI-generated summary from trial data · Aug 2, 2026 · Not medical advice
United States